26-27 Jan | FREE virtual study fair | REGISTER NOW 26-27 Jan | FREE virtual study fair | REGISTER NOW
University College London Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Edinburgh Featured PhD Programmes

qub PhD Projects, Programs & Scholarships

We have 106 qub PhD Projects, Programs & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 106 qub PhD Projects, Programs & Scholarships

PhD saved successfully
Last chance to apply

BIOmarkers TO Predict Evolving paediatric infections (BIOTOPE3)

  Research Group: Wellcome-Wolfson Institute for Experimental Medicine
*Application closing date has been extended from 24 to 31 January 2022*. Paediatric sepsis affects approximately 1.2 million children worldwide ever year and is a leading cause of death amongst children in the UK. Read more
Last chance to apply

Identification and characterisation of somatic non-coding mutations that influence cancer development and progression

  Research Group: The Patrick G Johnston Centre for Cancer Research
*Application closing date has been extended from 24 to 31 January 2022*. The role of non-coding somatic mutations in driving the development of cancer is largely unknown. Read more
Last chance to apply

Which symptoms matter most to people affected by dementia with Lewy bodies?

  Research Group: Centre for Public Health
*Application closing date has been extended from 24 to 31 January 2022*. Dementia with Lewy bodies (DLB) is the second most common form of dementia. Read more
Last chance to apply

Obtaining a genetic Diagnostic Yield via assessment of in-utero Scan findings prior to the introduction of SEquencing retrospectivelY (ODYSSEY) – a cohort study

  Research Group: Centre for Public Health
*Application closing date has been extended from 24 to 31 January 2022*. With the introduction of novel genomic technologies it is now possible to significantly shorten the diagnostic odyssey that children with rare disease and their parents endure. Read more
Last chance to apply

Machine learning to predict progression of glaucoma

  Research Group: Centre for Public Health
*Application closing date has been extended from 24 to 31 January 2022*. Glaucoma is a major cause of vision loss worldwide and one of the leading causes of blindness in Western Europe. Read more
Last chance to apply

Artificial intelligence for mapping evidence to target unmet needs of people with vision impairment in low- and middle-income countries

  Research Group: Centre for Public Health
*Application closing date has been extended from 24 to 31 January 2022*. A key step for planning health interventions for unmet needs in LMICs is mapping the evidence on the impact of these unmet needs. Read more
Last chance to apply

Integrative Data-intensive Analytics to Discover Novel Therapies and Companion Diagnostics for Precision Oncology

  Research Group: The Patrick G Johnston Centre for Cancer Research
This integrative drug discovery project applies and develops sophisticated computational techniques to analyse multiomics data for precision oncology, building upon our recently published ‘SynLeGG’ resource (. Read more
Last chance to apply

Structural, functional and molecular changes at the human peripheral retina

  Research Group: Wellcome-Wolfson Institute for Experimental Medicine
The major aim of this study is to explore the relationship between structural, functional and molecular changes at the human peripheral retina using state of the art clinical imaging and functional testing, supplemented by molecule characterisation using cadaveric eyes. Read more
Last chance to apply

Decoding chromatin accessibility signature in squamous cell carcinomas.

  Research Group: The Patrick G Johnston Centre for Cancer Research
*Application closing date has been extended from 24 to 31 January 2022*. Single-cell chromatin (in)accessibility architecture will shed light on a central question of epigenomic regulation. Read more
Last chance to apply

Exploiting the cell death and immune-modulatory effects of epigenetic modifiers to enhance efficacy of ADT-radiotherapy in prostate cancers.

  Research Group: The Patrick G Johnston Centre for Cancer Research
*Application closing date has been extended from 24 to 31 January 2022*. Androgen Deprivation Therapy (ADT) and radiotherapy combination is highly effective in patients with locally-advanced prostate cancer, yet >30% of patients relapse within 3- years. Read more
Last chance to apply

Targeting the USP7-PRC1-H2AK119Ub axis in cancer stem cells, a new therapeutic approach in colorectal cancer.

  Research Group: The Patrick G Johnston Centre for Cancer Research
*Application closing date has been extended from 24 to 31 January 2022*. Our team is interested in mechanisms of epigenetic regulated in stem cells and cancer. Read more
Last chance to apply

Molecular subtyping to identify therapeutic options in colorectal cancer

  Research Group: The Patrick G Johnston Centre for Cancer Research
*Application closing date has been extended from 24 to 31 January 2022*. Our lab (. https://dunne-lab.com/. ) is looking to recruit a translational bioinformatics PhD student, who will work within a highly-collaborative research team, to improve our understanding of colorectal cancer. Read more

Filtering Results